12.5 mg of tirzepatide (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects MOUNJARO 12.5 MG / 0.5

Is this tastier

If you see these patterns in any GLP-1 telehealth platform's marketing, they are the exact claims FDA has called misleading: Calling compounded semaglutide or tirzepatide a "generic" version of Ozempic or Wegovy - compounded drugs are not FDA-approved generics Implying FDA approved or reviewed the compounded product for safety, effectiveness, or quality - the FDA hasn't Claiming the pharmacy is "FDA-approved" or "FDA-licensed" - FDA registers facilities but does not "approve" or "license" compounding pharmacies in the way that phrase implies Branding compounded medication with the telehealth company's name in a way that suggests the telehealth company is the compounder - they're not Any messaging that implies the compounded product is "clinically proven" to perform the same as the FDA-approved branded drug This article avoids all of those patterns

Ozempic and Mounjaro might be covered for diabetes treatment, depending on your insurer

Progress monitoring: Regularly assess patient response to treatment and adjust dosage as clinically indicated